Author

Bre-Anne Fifield

University of WindsorORCID 0000-0002-1302-5210Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Lisa Ann PorteriD· 2 shared Alan CieslukowskiiD· 1 shared Alexander Rodzinka· 1 shared Alexandra Sorge· 1 shared Amy Basilious· 1 shared Catalin Gramisteanu· 1 shared Claudia Pecoraro· 1 shared Dalton Liwanpo· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Lisa Ann PorterORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Atypical Cell Cycle Regulation over Neural Stem Cell Expansion

Dorota Lubanska, Ingrid Qemo, Keith Franklin Stringer, Hema Priya Mahendran, Bre‐Anne Fifield, Alan Cieslukowski, Sami Alrashed, Youshaa El-Abed, Emmanuel Joran Boujeke, Alexander Rodzinka, Elizabeth Fidalgo da Silva, Stephanie Dinescu, Alexandra Sorge, Srinath Kandalam, Dalton Liwanpo, , Lisa Ann Porter

This study shows that increased Spy1 expression in neural stem cells enhances stemness, reduces differentiation, and promotes oncogenic transformation in mice.

Stem Cell Reports · Jan 1, 2026Peer-reviewedMolecular Biology

The Cyclin-Like Protein Spy1 Mediates Tumourigenic Potential of Triple Negative Breast Cancer

Bre-Anne Fifield, Claudia Pecoraro, Amy Basilious, Catalin Gramisteanu, Emily Mailloux, Rosa-Maria Ferraiuolo, Lisa A. Porter

This study shows that knocking out Spy1 reduces proliferation, metastasis, and stemness in triple negative breast cancer cells and enhances chemotherapy response.

bioRxiv · Mar 11, 2024 · PreprintCancer Biology